Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
PLoS One
; 11(6): e0157397, 2016.
Article
in En
| MEDLINE
| ID: mdl-27308830
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Estrogen
/
Gene Expression Regulation, Neoplastic
/
Src-Family Kinases
/
Drug Resistance, Neoplasm
/
Antineoplastic Agents, Hormonal
/
Dasatinib
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
PLoS One
Year:
2016
Document type:
Article